LANXESS set to showcase cutting-edge infection control solutions
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
The cGMP-4 facility will further strengthen the company's ability to serve global partners
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Subscribe To Our Newsletter & Stay Updated